DRIO - Company ID 0001533998
The table below shows DarioHealth Corp.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$6.03M | -$6.67M | -$13.11M | -$4.76M | -$18.09M | -$10.53M |
| Capital expenditure | $31.00K | $31.00K | $56.00K | $74.00K | $66.00K | $68.00K |
| Investing cash flow | -$826.00K | -$31.00K | -$8.85M | -$4.36M | -$181.00K | -$2.54M |
| Dividends paid | - | - | - |
DarioHealth Corp. reported operating cash flow of -$25.94M for fiscal year 2025. That is up 32.7% from -$38.56M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$8.38M (FY 2016) to -$25.94M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | - | $6.82M | $20.21M | -$1.39M | $38.02M | $65.71M |